Related Experiment Videos
Laparoscopic lymphadenectomy for gynecologic malignancies.
P R Dottino1, D H Tobias, A Beddoe
1Division of Gynecologic Oncology, Mount Sinai Medical Center, New York, New York 10029, USA.
Gynecologic Oncology
|June 15, 1999
Summary
Laparoscopic lymphadenectomy is a feasible surgical option for gynecologic cancers, demonstrating safety and effective lymph node removal. Outcomes improved with surgeon experience, potentially reducing hospital stays compared to open surgery.
Area of Science:
- Gynecologic Oncology
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Lymphadenectomy is crucial for staging and treating gynecologic malignancies.
- Minimally invasive techniques are increasingly explored to improve patient outcomes.
- Laparoscopic approaches offer potential benefits over traditional laparotomy.
Purpose of the Study:
- To evaluate the 5-year experience with laparoscopic lymphadenectomy in gynecologic cancer patients.
- To assess the feasibility, safety, and efficacy of this surgical approach.
Main Methods:
- Prospective data collection on 94 patients undergoing laparoscopic lymphadenectomy (pelvic and/or paraaortic) for various gynecologic malignancies between 1992 and 1998.
- Analysis of patient demographics, surgical procedures, outcomes, and hospital stay.
Main Results:
- 94 laparoscopic lymphadenectomies performed for cervical, ovarian, endometrial, and other gynecologic cancers.
- Mean hospital stay was 3.6 days for laparoscopic lymphadenectomy alone, with variations based on neoadjuvant chemotherapy.
- Increased nodal yield observed with growing operator experience; 3 conversions to laparotomy were required.
Conclusions:
- Laparoscopic lymphadenectomy is technically feasible and safe for gynecologic malignancies.
- The procedure provides adequate nodal yield, which improves with surgeon experience.
- Laparoscopic lymphadenectomy may lead to shorter hospital stays compared to open surgery.